Kyowa Hakko Kirin Co., Ltd., a pharmaceutical company built on the solid foundation of biotechnologies, applies its advanced technological expertise in therapeutic antibody and its years of R&D in focused areas to develop new pharmaceuticals in a shorter lead time, thus delivering new value to the medical industry. The company is committed to becoming a Japan-based global pharmaceutical specialist that contributes to the health and prosperity of people around the world. To achieve this goal, it puts its proprietary, cutting-edge technologies to the best advantage when developing and marketing groundbreaking new drugs through its global network.

Kyowa Hakko Bio Co., Ltd., the biochemical arm of the Kyowa Hakko Kirin Group, has innovated ways to develop value-added amino acids and other diverse products in the pharmaceutical and healthcare sectors. The company markets pharmaceuticals and health foods globally to help people around the world enjoy healthy, fulfilling lives.